FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952334241> ?p ?o ?g. }

• W2952334241 endingPage "744" @default.
• W2952334241 startingPage "734" @default.
• W2952334241 abstract "Nonviral gene therapy with specific short interfering RNAs (siRNAs) against BCR-Abl can be an alternative and/or supportive therapy of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKIs), given the often observed resistance to TKIs in clinical setting. In this study, we explored the feasibility of BCR-Abl siRNA therapy in CML K562 cells in vitro by employing a cationic polymer derived from cholesterol (Chol) grafted low-molecular weight polyethyleneimine (PEI). The first generation TKI imatinib upregulated the expression of BCR-Abl in K562 cells as expected. Delivery of BCR-Abl siRNA in both drug-sensitive and drug-resistant K562 cells significantly downregulated the mRNA levels in both cell types. Similarly, the BCR-Abl siRNA treatment arrested the growth of both drug-sensitive and drug-resistant K562 cells with no obvious differences despite a large difference in drug responsiveness. The BCR-Abl gene silencing in combination with TKI treatments exhibited significant synergism in drug-resistant K562 cells in generating substantial antileukemic activity, where the TKIs on their own were not effective. The effect of BCR-Abl siRNA and TKIs on non-CML cells (Jurkat and primary fibroblast) was negligible, indicating the specificity of the proposed therapy. This strategy can significantly overcome TKI resistance in CML cells, suggesting a feasible and effective treatment model for CML patients suffering from clinical resistances." @default.
• W2952334241 created "2019-06-27" @default.
• W2952334241 creator A5005848557 @default.
• W2952334241 creator A5027980410 @default.
• W2952334241 creator A5046233977 @default.
• W2952334241 creator A5057759442 @default.
• W2952334241 creator A5077150206 @default.
• W2952334241 date "2019-06-01" @default.
• W2952334241 modified "2023-10-15" @default.
• W2952334241 title "<i>BCR-Abl</i>Silencing by siRNA: A Potent Approach to Sensitize Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitor Therapy" @default.
• W2952334241 cites W1973633457 @default.
• W2952334241 cites W1979839164 @default.
• W2952334241 cites W1989422861 @default.
• W2952334241 cites W1994682335 @default.
• W2952334241 cites W1997254819 @default.
• W2952334241 cites W1999614615 @default.
• W2952334241 cites W2000651827 @default.
• W2952334241 cites W2000746048 @default.
• W2952334241 cites W2012153991 @default.
• W2952334241 cites W2015616444 @default.
• W2952334241 cites W2016656445 @default.
• W2952334241 cites W2028959752 @default.
• W2952334241 cites W2031313479 @default.
• W2952334241 cites W2033523236 @default.
• W2952334241 cites W2040323778 @default.
• W2952334241 cites W2052829673 @default.
• W2952334241 cites W2060797161 @default.
• W2952334241 cites W2068834508 @default.
• W2952334241 cites W2071038036 @default.
• W2952334241 cites W2074198797 @default.
• W2952334241 cites W2075482022 @default.
• W2952334241 cites W2082580993 @default.
• W2952334241 cites W2086344594 @default.
• W2952334241 cites W2088110670 @default.
• W2952334241 cites W2090004346 @default.
• W2952334241 cites W2102080480 @default.
• W2952334241 cites W2102756626 @default.
• W2952334241 cites W2106555552 @default.
• W2952334241 cites W2107268345 @default.
• W2952334241 cites W2113703021 @default.
• W2952334241 cites W2126235458 @default.
• W2952334241 cites W2145505953 @default.
• W2952334241 cites W2148743957 @default.
• W2952334241 cites W2151486690 @default.
• W2952334241 cites W2162567359 @default.
• W2952334241 cites W2166654361 @default.
• W2952334241 cites W2167919862 @default.
• W2952334241 cites W2202126706 @default.
• W2952334241 cites W2341921195 @default.
• W2952334241 cites W2532456746 @default.
• W2952334241 cites W256521491 @default.
• W2952334241 cites W2608108364 @default.
• W2952334241 cites W2612395793 @default.
• W2952334241 cites W2710462761 @default.
• W2952334241 cites W2757770663 @default.
• W2952334241 cites W2795669086 @default.
• W2952334241 cites W2808764596 @default.
• W2952334241 cites W4246876072 @default.
• W2952334241 cites W782389661 @default.
• W2952334241 doi "https://doi.org/10.1089/scd.2018.0196" @default.
• W2952334241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30585758" @default.
• W2952334241 hasPublicationYear "2019" @default.
• W2952334241 type Work @default.
• W2952334241 sameAs 2952334241 @default.
• W2952334241 citedByCount "13" @default.
• W2952334241 countsByYear W29523342412019 @default.
• W2952334241 countsByYear W29523342412020 @default.
• W2952334241 countsByYear W29523342412021 @default.
• W2952334241 countsByYear W29523342412022 @default.
• W2952334241 countsByYear W29523342412023 @default.
• W2952334241 crossrefType "journal-article" @default.
• W2952334241 hasAuthorship W2952334241A5005848557 @default.
• W2952334241 hasAuthorship W2952334241A5027980410 @default.
• W2952334241 hasAuthorship W2952334241A5046233977 @default.
• W2952334241 hasAuthorship W2952334241A5057759442 @default.
• W2952334241 hasAuthorship W2952334241A5077150206 @default.
• W2952334241 hasBestOaLocation W29523342411 @default.
• W2952334241 hasConcept C104317684 @default.
• W2952334241 hasConcept C119056186 @default.
• W2952334241 hasConcept C121608353 @default.
• W2952334241 hasConcept C125418893 @default.
• W2952334241 hasConcept C171122931 @default.
• W2952334241 hasConcept C179464577 @default.
• W2952334241 hasConcept C203014093 @default.
• W2952334241 hasConcept C22615655 @default.
• W2952334241 hasConcept C2776090121 @default.
• W2952334241 hasConcept C2776960273 @default.
• W2952334241 hasConcept C2777583451 @default.
• W2952334241 hasConcept C2778461978 @default.
• W2952334241 hasConcept C2778729363 @default.
• W2952334241 hasConcept C2778820342 @default.
• W2952334241 hasConcept C42362537 @default.
• W2952334241 hasConcept C43907098 @default.
• W2952334241 hasConcept C502942594 @default.
• W2952334241 hasConcept C54009773 @default.
• W2952334241 hasConcept C54355233 @default.
• W2952334241 hasConcept C55493867 @default.
• W2952334241 hasConcept C62478195 @default.

• next